Results 31 to 40 of about 40,172 (208)

Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infection. [PDF]

open access: yesPLoS ONE, 2013
In industrialized countries bacterial intestinal infections are commonly caused by enteropathogenic Enterobacteriaceae. The interaction of the microbiota with the host immune system determines the adequacy of an appropriate response against pathogens. In
Alexandra Wittmann   +2 more
doaj   +1 more source

Mobilizing plasmacytoid dendritic cells [PDF]

open access: yesBlood, 2017
In this issue of Blood , Schroeder et al demonstrate striking mobilization of plasmacytoid dendritic cell progenitors (pre-pDCs) and mature plasmacytoid dendritic cells (pDCs) into the vascular compartment along with CD34 + hematopoietic progenitor cells following administration of single-agent plerixafor in sibling donors ...
openaire   +2 more sources

Blastic plasmacytoid dendritic cell neoplasm

open access: yesClinical Case Reports, 2018
Key Clinical MessageBlastic plasmacytoid dendritic cell neoplasm is an aggressive neoplasm with a median survival of only a few months despite treatment. An exhaustive immunohistochemical workup is required to differentiate it from myeloid sarcoma and extranodal NK/T cell lymphoma.
Manoj Ponadka Rai   +4 more
openaire   +4 more sources

Blastic plasmacytoid dendritic cell neoplasm [PDF]

open access: yesMedicina Clínica (English Edition)
Blastic plasmacytoid dendritic cell neoplasm is an uncommon, aggressive hematologic neoplasm carrying a poor prognosis with a median survival of one year, making early detection vital. Patients present with a number of characteristic cutaneous manifestations and are treated with chemotherapy and hematopoietic stem cell transplantation, which may ...
Lasheras-Pérez MA   +2 more
  +8 more sources

A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who underwent allogeneic stem cell transplantation: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Blastic plasmacytoid dendritic cell neoplasm represents a rare type of hematologic malignancy that often manifests itself through various skin lesions. It commonly affects the elderly male population.
Fateme Salemi   +5 more
doaj   +1 more source

Murine thymic plasmacytoid dendritic cells [PDF]

open access: yesEuropean Journal of Immunology, 2003
AbstractWe report herein heterogeneous murine thymic cell subsets expressing CD11c and B220 (CD45R). The CD11c+B220+ subset expresses Ly6Chigh and MHC class IIlow in contrast with previously described thymic DC (CD11c+B220– cells). Freshly isolated thymic CD11c+B220+ cells show typical plasmacytoid morphology which differentiates to mature DC, in vitro
Tomoyuki, Okada   +5 more
openaire   +2 more sources

CXCR3 chemokine receptor contributes to specific CD8+ T cell activation by pDC during infection with intracellular pathogens.

open access: yesPLoS Neglected Tropical Diseases, 2020
Chemokine receptor type 3 (CXCR3) plays an important role in CD8+ T cells migration during intracellular infections, such as Trypanosoma cruzi. In addition to chemotaxis, CXCR3 receptor has been described as important to the interaction between antigen ...
Camila Pontes Ferreira   +9 more
doaj   +1 more source

Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement

open access: yesNature Communications, 2017
Plasmacytoid dendritic cells produce type I interferons in response to viral sensing. Here the authors show that amines inhibit these plasmacytoid dendritic cell responses through CXCR4 engagement.
Nikaïa Smith   +17 more
doaj   +1 more source

Immunoinflammatory cells and Beta-defensin-3 in radicular cysts of primary and permanent teeth [PDF]

open access: yesBrazilian Oral Research
: The expression of hBD-3 and quantification of immune and inflammatory response cells (non-degranulated and degranulated mast cells, mature and immature plasmacytoid dendritic cells, mature and immature Tregs, T lymphocytes, cytotoxic T lymphocytes, and
Amanda Silva Bertasso   +8 more
doaj   +2 more sources

FMS-like tyrosine kinase 3 ligand treatment does not ameliorate experimental rapidly progressive glomerulonephritis. [PDF]

open access: yesPLoS ONE, 2015
Fms-like tyrosine kinase 3-ligand (FL) is a growth factor that may expand dendritic cell and regulatory T cell populations. We hypothesised that FL-induced regulatory T cells would protect mice from experimental rapidly progressive glomerulonephritis. To
Joanna R Ghali   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy